ABSTRACT The presence of particular surface carbohydrate modifications is shown to affect dramatically the stability and tissue specificity of unilamellar distearoyl Khosphatidylcholine vesicles in mice. Use of the 7-ray probe 1 In3 permits analysis of tissue distributions by standard y counting techniques and determination of the structural integrity of the vesicles by perturbed angular correlation spectroscopy. Addition of a 6-aminomannose derivative of cholesterol to the lipid bilayer produces initial retention of high levels of intact vesicles in the lung after intravenous injection followed by concentration of intact vesicles in the liver and spleen. Vesicles bearing 6-aminosugar residues are found to concentrate in the axillary space in aggregates of polymorphonuclear leukocytes when administered subcutaneously. The in vivo stability of 6-aminomannose-labeled vesicles is substantially greater after intravenous or subcutaneous administration than that observed for any other system examined. The dose-response effects observed with surface modifications indicate that a particular receptor topography is important in the mechanism leading to transport and destruction of these vesicles.
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The use of liposomes as carriers for delivery of therapeutic and diagnostic agents to specific targets within the body has been under investigation by a large number of research groups. The complex problems encountered in in vivo therapeutic applications (1) clearly suggest the necessity to increase the specificity of liposome targeting. To obtain satisfactory targeting of administered agents, the liposomes must not only reach the appropriate tissue but must also release their contents at the desired time.
Complex carbohydrates are involved in many biological recognition processes including antibody and toxin recognition and cellular adhesion (2) . Of particular interest are the findings by Huang (3) and Bussian and Wriston (4) that the interaction of glycolipid-bearing vesicles with cultured cells is carbohydrate specific. This suggests that expansion of our previous studies on in vwo vesicle stability (5, 6 ) may provide insight into the determinants required for recognition by particular tissues. We report here the effects of particular surface carbohydrate modifications on lipid vesicle stability and tissue specificity in mice. These surface modifications are achieved by incorporating carbohydrate derivatives of cholesterol into the lipid bilayer. The use of vesicles containing high levels of II'In3+ (7) permits analysis of tissue distributions by standard T counting techniques and determination of the structural integrity of the vesicles by perturbed angular correlation spectroscopy (PAC) (5, 6) . Preliminary findings (8) with this approach indicated that vesicles with aminosugar derivatives have the greatest longevity and a specificity for leukocytes. Cholesteryl [9,10-3H] oleate (specific activity, 11 Ci/g; 1 Ci = 3.7 X 1010 becquerels) and cholesteryl [1-14C] oleate (51 Ci/mol) were obtained from New England Nuclear. Carrier-free "'InCl3 was purchased from Medi+Physics (Glendale, CA) and purified as described (6) . The ionophore A23187 was a gift from Eli Lilly.
Preparation of Vesicles. Unilamellar vesicles with A23187 incorporated into the bilayer were prepared as described (5, 7) by probe sonication of lipid mixtures in a buffer solution consisting of 1 mM N(AcOH)3 in 0.9% NaCl/5 mM Na phosphate, pH 7.4. Vesicles of the following compositions (molar ratio) were prepared: Ste2PtdCho/Chol/A23187, 2:1:0.004; Ste2PtdCho/Chol/Cet2P/A23187, Ste2PtdCho/Chol/NSte/ A23187, and Ste2PtdCho/Chol/cholesterol derivative/A23187, all 2:0.5:0.5:0.004. All preparations contained A23187; therefore, reference to it will be omitted hereafter in the designated vesicle compositions. Tritiated (1 liCi) or 14C-labeled cholesteryl oleate (0.5 MCi) were included in the mixtures as a marker for the lipid phase.
After sonication, annealing, and low-speed centrifugation (7, 10) loaded with "'1In3+ under conditions described (5, 7) by utilizing A23187 to facilitate the transport of the "'In3+ to the chelator, N(AcOH)3, inside the vesicles.
Studies in Vivo. Vesicles containing lllIn3+ were administered to Swiss-Webster mice (18-22 g ) by intravenous (tail vein) or subcutaneous injection (near midline of the back at the level of the scapulae). The amount of lllIn3+ administered ranged between 10 and 160 ,Ci per mouse depending on the type of experiment (5) . The tissue distribution of injected radioactivity was determined by assaying all portions of the mouse in a well-type y-ray spectrometer. All recoveries were corrected to account for decay of the 11In3+ (t112 = 2.8 days). Typically, 4-12 mice were used for each group of time points.
To determine the residual blood content in various tissues, the tissue distribution of lllIn3+ was measured at 8 min after intravenous injection of radiolabeled Ste2PtdCho/Chol vesicles ( Table 1 ). Assuming that blood comprises 7.3% of the total weight of the animals, we found that 89.6 ± 14.1% of the injected radioactivity was in the blood. Thus, at 8 min, the vesicles were still principally in the bloodstream and the distribution of activity among the various tissues given in Table 1 represents the blood content of the various tissues. The values in Table 1 are in good agreement with previously reported organ blood content levels (11) . All tissue distributions reported at longer times are corrected for the activity due to residual blood content. For studies involving both intravenous and subcutaneous administration, the distributions are given as a percentage of the total recovered lllIn3+ because some loss may occur from the injection site, and errors can also occur in the measurement of the injected volumes. In all cases, blood was assumed to comprise 7.3% of the total weight of the animal.
Autoradiograms of the skin were made in the following manner. The pelt was carefully stretched over a flat surface, internal side facing up. Al foil (25 ,um) was placed over the pelt to protect the film (Kodak medical x-ray) which was sandwiched between the foil and a sheet containing activated ZnS phosphor. Exposure time was approximately 15 min.
Cytological characterization of nodules was based on microscopic examination. The tissue specimens were prepared for conventional microscopy by first embedding the sample in paraffin; 4-Asm sections were cut, stained, for 5 min in Harris hematoxylin/eosin reagent, and washed with water. RESULTS
Intravenous Injection. The Ste2PtdCho/Chol/NManChol vesicles showed substantially greater stability after intravenous administraiqn than did the other vesicle systems tested (Fig. 2) . The corresponding tissue distributions also indicate an anomalous behavior for these vesicles ( the aminomannose-bearing vesicles observed in these tissues accounts for the overall increased longevity observed in live animals with this system (Fig. 2) .
Subcutaneous Injection. Distributions of radioactivity among various tissues following subcutaneous injection are shown in Table 3 for various different vesicle compositions. For the first 12 hr after subcutaneous injection, the tissue distributions for all vesicle systems examined were similar (Table 3) . However, at long times (e.g., >72 hr), some differences in the tissue distributions were apparent. In particular, the aminomannose-bearing vesicles showed a higher level of 1llIn3+ in the skin than observed with the other vesicle systems, whereas the fraction retained in the liver appeared to increase for the non-aminomannose systems. It is of interest that the aminomannose vesicle system which retained a high fraction of activity in the skin at long times is also the system-shown previously (8) to have an extremely long half-time for vesicle destruction (i.e., 600 hr) after subcutaneous injection.
Within 1 hr after subcutaneous injection of vesicles bearing the aminosugar derivatives of cholesterol, a moist appearing, blister-like structure could be seen with the unaided eye. The swelling has been observed up to 8 hr after injection. With multilamellar vesicles bearing the aminomannose derivative, the localized swelling persisted up to 22 hr after subcutaneous administration.
The blebs coincided with the location of the II'In3+ (Fig. 3) .
The pattern observed in the autoradiogram shows that the bleb does not represent intact migration of the injection bolus. The radioactivity appeared confined within a fibrous structure. The bleb was examined on 4-.um-thick tissue sections by using a phase-contrast procedure and was found to be comprised of aggregates of polymorphonuclear leukocytes (Fig. 4) .
From the specific activity of the skin tissue, it was apparent that the Ste2PtdCho/Chol/NManChol vesicles were severalfold more concentrated in the skin than were vesicles of other 
DISCUSSION
Modification of the surface characteristics of lipid vesicles through incorporation into the bilayer of various derivatives of cholesterol has been shown to alter markedly the in vtvo stability and tissue specificity of the vesicles. Of the derivatives studied, those with a primary amine group at C-6 of the sugar moiety showed the most enhanced stability. When administered subcutaneously, in vivo half-times of 100 and 600 hr were found for the aminogalactose and aminomannose systems, respectively, compared to a half-time of 21 hr for the control Ste2PtdCho/Chol systems (8) . This is a much greater enhancement than anticipated from findings with unsubstituted sugar derivatives or with NSte incorporated into the bilayer.
The effects observed with the aminosugar derivatives may be attributed to the stereochemical positioning of the amino group at C-6. This amine should be highly exposed on the vesicle surface. The differences in in vivo stability between the aminogalactose-and aminomannose-bearing vesicles -may arise from two types of stereochemical changes. One of these is a structural difference at the anomeric carbon. The galactose derivatives used here were 3 isomers; the mannose derivatives were a isomers. The other type of change is epimerizations at C-2 and C-4. With the derivatives available, the relative effects of these two types of changes cannot yet be evaluated. The population of amine groups on the vesicle surface also is an important factor in vesicle behavior. A 50% reduction in the amount of aminomannose derivative (i.e., Ste2PtdCho/ Chol/NManChol at 2:0.75:0.25) caused a substantial reduction in the extent of localization and a marked decrease in in vivo vesicle stability. As reported (8) , when the level of aminomannose is lowered still further (i.e., Ste2PtdCho/Chol/ NManChol at 2:0.9:0.1), no bleb formation is observed in the Biochemistry: Mauk et al. axillary space. This suggests that a certain concentration of groups on the vesicle surface is required to produce the longevity and tissue specificity observed. Such a dose-response effect is not unique. For example, in studying model systems for cell-cell agglutination, Curatolo et al. (12) found that vesicles must contain at least 5 mol % of the glycolipid lactosylceramide to be agglutinated by a plant lectin. At higher glycolipid contents, agglutination increased with increasing glycolipid content.
The anomalous behavior exhibited by vesicles bearing aminosugar derivatives of cholesterol suggests that a particular receptor topography is important in the mechanism leading to transport and destruction of these vesicles. After subcutaneous injections, these vesicles do not remain at the site of injection but are found in blebs in the axillary space. The blebs are filled with aggregates of polymorphonuclear leukocytes. The detailed explanation for these effects must include steps such as the recognition of the aminosugar receptor analogues, the production of a chemotactic factor to attract the leukocytes, the transport of the vesicles along with the leukocytes to the axillary space, and the eventual destruction of the vesicles.
Information on whether similar steps are involved in the processing of aminosugat-bearing vesicles when they are injected intravenously is obtained from tissue distribution data for aminomannose-bearing vesicles. With this vesicle system, a pattern of rapid clearance from the blood with early deposition in the lungs and then subsequent accumulation in liver and spleen is observed. Comparison of these data with patterns observed after intravenous administration of "'lIn-oxine-labeled wleukocytes (13, 14) reveals little similarity. However, our data bear a marked resemblance to tissue distributions observed after administration of "1'In-oxine-labeled heat-damaged leukocytes in both rats (13) and rabbits (15) . Thus our intravenous results suggest that, after recognition, the aminomannose vesicles could interact with similar cell types, causing these cells to undergo a change (e.g., in surface markers) that leads to these cells being earmarked for destruction. The aminomannose vesicles might remain with the cell, with the vesicles existing intact for extended periods, and hence would exhibit the tissue distribution observed for heat-killed cells.
Our approach of systematically investigating surface groups on lipid vesicles is directed at identifying modifications that will allow the vesicles to be recognized by specific tissues. Various other approaches including use of specific antibodies (16) and receptor-bearing particles (17) have been tried in attempts to achieve targeting. Our experimental results with carbohydrates as phospholipid vesicle surface modifications are consistent with the growing body of information implicating glycolipids as cell surface receptors (2, 12, 18) . Our findings indicate that further study of mechanisms of recognition and transport of aminosugar-labeled vesicles in evo and examination of additional carbohydrate derivatives could provide a major advance toward achieving targeting and controlled release of vesicle contents.
